Biopharmaceutical firm Syneos invests in Indegene unit

Biopharmaceutical firm Syneos invests in Indegene unit
Photo Credit: Thinkstock
10 Jan, 2020

Bengaluru-based Indegene, a healthtech startup focussed on the global life sciences industry, announced Syneos Health as a strategic collaborator and minority investor in Indegene Omnipresence, which is a wholly-owned subsidiary of Indegene.

Syneos Health has invested an undisclosed amount in Indegene Omnipresence.

Omnipresence is a unified customer experience platform for healthcare and life sciences organisations with CRM ( Customer Experience Management), omnichannel engagement, advanced analytics, and AI (Artificial Intelligence) capabilities in a single unified platform, a company statement said.

The Omnipresence platform, built with Microsoft in 2017, claims to bring together Microsoft Azure analytics as well as Microsoft AI together with Microsoft Dynamics 365 and Power Platform for business applications, and Microsoft Office 365 and Teams for productivity and collaboration.

"With this investment, Indegene Omnipresence will significantly strengthen its position as the next-generation Customer Experience Management platform through expanded global resources and expertise, providing a much-needed option to meet the dramatically changing needs of the industry," Rajesh Nair, co-founder and President, Indegene, said.

Syneos Health provides end-to-end drug development and commercialisation solutions to biopharmaceutical customers in more than 110 countries.

"This investment will further accelerate the roadmap and deployments of our Customer Experience Management (CXM) platform for life sciences and healthcare clients," Manish Gupta, co-founder and CEO of Indegene, said.

Recent deals in health-tech space

Jan 2020: Retail pharmacy chain Generico, raised $1.39 million in a venture debt funding from Alteria Capital. https://www.techcircle.in/2020/01/07/generico-raises-1-39-mn-venture-debt-from-alteria-capital 

December 2019: Bengaluru-based Medlife International, which operates an online pharmacy, raised $15 million via non-convertible debentures from Mauritius-based Wilson Global Opportunities Fund.

December 2019: Gurugram headquartered multispeciality clinic chain for elective surgeries, Pristyn Care, raised $12 million in a Series B round from Hummingbird Ventures, Greenoaks Capital, AngelList and returning investor Sequoia Capital India.

Comment(s)